Therefore, the fact that DOT1L-deletion rendered a highly aggressive TP53 mutant blast-phase MPN model sensitive to LSD1 inhibition causing growth arrest and even induction of apoptosis is remarkable and demands further preclinical exploration. This evidence concerns the gene DOT1L and myeloproliferative disorder.